Aubagio Tablet, Film Coated
Product Images NDC 58468-0210

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aubagio (NDC 58468-0210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Teriflunomide 01)

Chemical structure of teriflunomide, the active ingredient in Aubagio, showing the molecular arrangement including a trifluoromethyl-substituted phenyl ring and associated functional groups.*

FDA Label Image

Figure 1 (Teriflunomide 02)

A line graph comparing disability progression sustained for 12 weeks (%) over time in weeks for Placebo, 7 mg Aubagio, and 14 mg Aubagio. The y-axis represents percentage of disability progression, and the x-axis shows weeks up to 108. The plot indicates lower progression percentages for 7 mg and 14 mg Aubagio groups compared to placebo. A table below the x-axis shows the number of patients at risk at various time points for each group.*

FDA Label Image

Figure 2 (Teriflunomide 03)

A line graph showing disability progression sustained for 12 weeks (%) over a period of 108 weeks for placebo, 7 mg Aubagio, and 14 mg Aubagio. The chart includes a number at risk table below the x-axis, with distinct lines for each treatment group indicating their respective progression rates over time, with 14 mg Aubagio showing lower progression compared to placebo and 7 mg Aubagio.*

FDA Label Image

Principal Display Panel (7 mg Tablet Bottle Carton)

Packaging label for Aubagio 7 mg tablets, film-coated oral tablets containing teriflunomide as the active ingredient. The label shows a 30-tablet supply and includes dosage strength, storage instructions, and manufacturer information. The labeler is Genzyme Corporation, a Sanofi company, with NDC 58468-0211-4 indicated.*

FDA Label Image

Principal Display Panel (14 mg Tablet Bottle Carton)

Aubagio 14 mg film-coated tablets carton label featuring teriflunomide as the active ingredient. The label indicates a 30-tablet count along with dosing instructions and storage conditions. It is labeled for prescription use only, manufactured by Genzyme Corporation, a Sanofi company, with manufacturing origin noted as Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.